Maureen Orr

Ms. Maureen Orr

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2018 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
SMSutapa Mukhopadhyay
Sutapa Mukhopadhyay
AHAnnie Hirsch
Annie Hirsch
SESuze Etienne
Suze Etienne
NMNatalia Melnikova
Natalia Melnikova
JWJennifer Wu
Jennifer Wu
MOMaureen Orr
Maureen Orr

20 March 2020 in Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
NMNatalia Melnikova
Natalia Melnikova
JWJennifer Wu
Jennifer Wu
PRPatricia Ruiz
Patricia Ruiz
MOMaureen Orr
Maureen Orr
CDC summarizes 2010-2014 data from the National Toxic Incidents Program, which collected data on any uncontrolled or illegal acute (lasting <72 hours) release of any toxic substance including chemical, biologic, radiologic, and medical materials.

11 March 2025 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
SBSydney Boone
Sydney Boone
WSWenjie Sun
Wenjie Sun
PGPavani Gonnabathula
Pavani Gonnabathula
JWJennifer Wu
Jennifer Wu
MOMaureen Orr
Maureen Orr
Patricia RuizPatricia Ruiz
Patricia Ruiz
Chemical release incidents in the United States involve hazardous chemicals that can harm nearby communities. A historical tracking of these chemical release incidents from 1991 to 2014 across up to 16 states has been conducted by The Agency for Toxic Substances and Disease Registry (ATSDR), utilizing the Hazardous Substances Emergency Events Surveillance (HSEES) and the National Toxic Substance Incidents Program (NTSIP) systems. By analyzing surveillance data, patterns of these different chemical releases can be identified to develop and construct a health-protective course of action. Physiologically Based Pharmacokinetic (PBPK) models can simulate chemical exposures during acute chemical incidents. For a retrospective study of an acute chemical release in 2012, we examined the components necessary to integrate PBPK-modeled exposure assessments in ATSDR’s Assessment of Chemical Exposure (ACE) program. We focused on data from a published investigation of vinyl chloride (VC) exposure to assess the utility of PBPK in evaluating exposures among residential populations near the release site. The initial estimate from the real-time air monitoring at the release site revealed that air levels greatly exceeded the Acute Exposure Guideline Levels (AEGL) of 1200 ppm, with PBPK models predicting corresponding VC blood levels of 3.17 mg/L. “Real-time” and “after-action” air modeling estimated VC levels at various distances from the release site over time. PBPK modeling provided insight into possible residential blood levels of VC over several days following the incident. These findings indicate that PBPK modeling could be valuable for reconstructing exposure scenarios associated with acute chemical releases.

2 December 2025 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
MDMelissa Dvm Dulcey
Melissa Dvm Dulcey
VMValerie Madera-Garcia
Valerie Madera-Garcia
DSDallas S. Shi
Dallas S. Shi
VPVidisha DrPH Parasram
Vidisha DrPH Parasram
BGBeatrice Dnp Gichuhi
Beatrice Dnp Gichuhi
TLTheodore C. Larson
Theodore C. Larson
Objective This study aimed to evaluate chemical exposures and health effects after a train derailment in Ohio, near the Pennsylvania border. Methods Cross-sectional data (February–March 2023) on symptoms, exposures, medical care, and needs were collected using the Assessment of Chemical Exposures toolkit. Associations between exposures and symptoms were analyzed using logistic regression. Results Participants reported chemical exposures (86%), mental health symptoms (70%), and physical symptoms (92%). Ears, nose, or throat symptoms (80%) and headache (76%) were the most common. Forty-one percent sought medical care, and 44% had unmet needs. Participants aged 18–64 years had higher odds of experiencing ophthalmic (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.04–2.19), neurological (OR, 2.40; 95% CI, 1.51–3.83), and dermatological symptoms (OR, 1.50; 95% CI, 1.04–2.15), compared with participants aged ≥65 years. Conclusions Most participants experienced chemical exposures, symptoms, and needs. Findings supported the establishment of a permanent health clinic. Export